Hirotsugu Atarashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hirotsugu Atarashi has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Inoue
Saiseikai Toyama Hospital Toyama Japan
9 shared publications- Ken Okumura
Division of Cardiology Saiseikai Kumamoto Hospital Kumamoto Japan
5 shared publications Takeshi Yamashita
The Cardiovascular Institute Tokyo Japan
5 shared publications- Eitaro Kodani
Department of Cardiovascular Medicine, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan
4 shared publications Hideki Origasa
Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate, School of Medicine and Pharmaceutical Sciences, Toyama, Japan
4 shared publications- Takeshi Yamashita
Department of Cardiovascular Medicine The Cardiovascular Institute Tokyo Japan
4 shared publications
Latest Publications
- Open Access
- 2 June 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (6) , e70158
Authors' Reply to “Questioning the Rhythm: A Closer Look at Heart Rate Trends”
- 2 June 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (6) , e70158
Open AccessAuthors' Reply to “Questioning the Rhythm: A Closer Look at Heart Rate Trends”
- Open Access
- 27 March 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (4) , e70122
Association Between Changes in Heart Rate and Adverse Events in Patients With Non‐Valvular Atrial Fibrillation: A Post Hoc Analysis of the J‐RHYTHM Registry
Background: We previously reported that the heart rate (HR) at the time closest to an event or at the last visit during the follow‐up period (HR‐end) was more closely associated with adverse events (AEs) than baseline HR in patients with non‐valvular atrial fibrillation (NVAF). However, it remains uncertain whether changes in HR during the follow‐up period or absolute HR values would be more closely associated with AEs. Thus, we performed post hoc analyses using data from the J‐RHYTHM Registry.Methods: Of 7406 outpatients with NVAF from 158 institutions, 6886 (age, 69.8 ± 9.9 years; men, 70.8%), who had both baseline HR and HR‐end data, were included. Patients were divided into five groups based on the changing patterns of HR quartiles from baseline (< 63, 63–70, 71–79, and ≥ 80 beats per minute) to the end of follow‐up (no‐change, down‐to‐the‐lowest‐quartile, down‐to‐the‐2nd or ‐3rd‐quartile, up‐to‐the‐2nd or ‐3rd‐quartile, and up‐to‐the‐highest‐quartile).Results: Hazard ratios for AEs were significantly higher only in the up‐to‐highest‐quartile group (2.89 [95% confidence interval, 1.71–4.90] for thromboembolism, 2.46 [1.53–3.95] for major hemorrhage, and 2.36 [1.51–3.70] for all‐cause death) compared with the no‐change group, after adjusting for confounding factors. Furthermore, in the no‐change group, hazard ratios for AEs were significantly higher in the highest‐to‐highest‐quartile subgroup (5.55 [1.49–20.77] for major hemorrhage and 3.60 [1.03–12.53] for all‐cause death) compared with the 2nd‐to‐2nd‐quartile subgroup.Conclusions: Both excessive increases in HR and consistently high HR were independently associated with AEs in patients with NVAF. By contrast, modest decrease in HR during follow‐up was associated with lower mortality. Accordingly, it is important to pay attention to changes in HR during follow‐up for the management of patients with AF.Clinical Trial Registration: The J‐RHYTHM Registry is registered in the University Hospital Medicine Information Network (UMIN) Clinical Trials Registry (unique identifier: UMIN000001569) http://www.umin.ac.jp/ctr/.
- 27 March 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (4) , e70122
Open AccessAssociation Between Changes in Heart Rate and Adverse Events in Patients With Non‐Valvular Atrial Fibrillation: A Post Hoc Analysis of the J‐RHYTHM Registry
Background: We previously reported that the heart rate (HR) at the time closest to an event or at the last visit during the follow‐up period (HR‐end) was more closely associated with adverse events (AEs) than baseline HR in patients with non‐valvular atrial fibrillation (NVAF). However, it remains uncertain whether changes in HR during the follow‐up period or absolute HR values would be more closely associated with AEs. Thus, we performed post hoc analyses using data from the J‐RHYTHM Registry.Methods: Of 7406 outpatients with NVAF from 158 institutions, 6886 (age, 69.8 ± 9.9 years; men, 70.8%), who had both baseline HR and HR‐end data, were included. Patients were divided into five groups based on the changing patterns of HR quartiles from baseline (< 63, 63–70, 71–79, and ≥ 80 beats per minute) to the end of follow‐up (no‐change, down‐to‐the‐lowest‐quartile, down‐to‐the‐2nd or ‐3rd‐quartile, up‐to‐the‐2nd or ‐3rd‐quartile, and up‐to‐the‐highest‐quartile).Results: Hazard ratios for AEs were significantly higher only in the up‐to‐highest‐quartile group (2.89 [95% confidence interval, 1.71–4.90] for thromboembolism, 2.46 [1.53–3.95] for major hemorrhage, and 2.36 [1.51–3.70] for all‐cause death) compared with the no‐change group, after adjusting for confounding factors. Furthermore, in the no‐change group, hazard ratios for AEs were significantly higher in the highest‐to‐highest‐quartile subgroup (5.55 [1.49–20.77] for major hemorrhage and 3.60 [1.03–12.53] for all‐cause death) compared with the 2nd‐to‐2nd‐quartile subgroup.Conclusions: Both excessive increases in HR and consistently high HR were independently associated with AEs in patients with NVAF. By contrast, modest decrease in HR during follow‐up was associated with lower mortality. Accordingly, it is important to pay attention to changes in HR during follow‐up for the management of patients with AF.Clinical Trial Registration: The J‐RHYTHM Registry is registered in the University Hospital Medicine Information Network (UMIN) Clinical Trials Registry (unique identifier: UMIN000001569) http://www.umin.ac.jp/ctr/.
- Open Access
Conventional electrode catheter placement can miss crucial atypical atrioventricular nodal reentrant tachycardia circuit details. -New insights into the retrograde slow pathways-
Background During atypical atrioventricular nodal reentrant tachycardia (AVNRT), the earliest atrial activation site following retrograde slow pathway (SP) conduction is at the atrial exit of the left inferior extension of the compact node (LIE) in the coronary sinus (CS) or the right inferior extension (RIE) on the tricuspid annulus (TA). We tested the validity of conventional electrode placement-based mapping of the atrial ends of these extensions. Methods We retrospectively evaluated the efficiency of the two catheter (His bundle and CS) mapping method for localization of LIE and RIE in atypical AVNRT patient using electroanatomical 3D mapping validation. Results Among 19 atypical AVNRTs (15 fast/slow and 4 slow/slow) in 14 patients (9 females, age 59±17), 8 AVNRTs had LIE involvement and 11 had RIE. The 8 LIE exits were inside the CS, and localization by 3D mapping and CS electrode catheter matched in all. In contrast, RIE exits were on the posterior TA where electrode catheters are conventionally not placed. All RIE exits required 3D mapping for accurate localization. During retrograde RIE conduction, comparison of the activation time of the CS ostium and HBE showed that the CS ostium was earlier in 7 RIEs, HBE was earlier in 1, and they were simultaneous in 3, resulting in the presence of RIE being missed in 4/11 (36%) AVNRTs using current diagnostic criteria. Activation time of the CS ostium and His bundle were determined by their relative closeness to the RIE exit. Conclusions Conventionally placed electrode catheter mapping in atypical AVNRT was able to identify 100% of LIE, but only 64% of RIE. It is critical to place a catheter on or use a 3D mapping system for the posterior TA in cases of suspected atypical AVNRT, so that all inferior extensions of the AV node can be identified and targeted for treatment.
Open AccessConventional electrode catheter placement can miss crucial atypical atrioventricular nodal reentrant tachycardia circuit details. -New insights into the retrograde slow pathways-
Background During atypical atrioventricular nodal reentrant tachycardia (AVNRT), the earliest atrial activation site following retrograde slow pathway (SP) conduction is at the atrial exit of the left inferior extension of the compact node (LIE) in the coronary sinus (CS) or the right inferior extension (RIE) on the tricuspid annulus (TA). We tested the validity of conventional electrode placement-based mapping of the atrial ends of these extensions. Methods We retrospectively evaluated the efficiency of the two catheter (His bundle and CS) mapping method for localization of LIE and RIE in atypical AVNRT patient using electroanatomical 3D mapping validation. Results Among 19 atypical AVNRTs (15 fast/slow and 4 slow/slow) in 14 patients (9 females, age 59±17), 8 AVNRTs had LIE involvement and 11 had RIE. The 8 LIE exits were inside the CS, and localization by 3D mapping and CS electrode catheter matched in all. In contrast, RIE exits were on the posterior TA where electrode catheters are conventionally not placed. All RIE exits required 3D mapping for accurate localization. During retrograde RIE conduction, comparison of the activation time of the CS ostium and HBE showed that the CS ostium was earlier in 7 RIEs, HBE was earlier in 1, and they were simultaneous in 3, resulting in the presence of RIE being missed in 4/11 (36%) AVNRTs using current diagnostic criteria. Activation time of the CS ostium and His bundle were determined by their relative closeness to the RIE exit. Conclusions Conventionally placed electrode catheter mapping in atypical AVNRT was able to identify 100% of LIE, but only 64% of RIE. It is critical to place a catheter on or use a 3D mapping system for the posterior TA in cases of suspected atypical AVNRT, so that all inferior extensions of the AV node can be identified and targeted for treatment.
- Open Access
- 19 October 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (12) , 2696-2705
Home Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry
Background: Blood pressure (BP) fluctuates significantly in patients with atrial fibrillation (AF); office BP measurements seem insufficient to assess AF patient risk accurately. We hypothesized that home BP could better predict the risk of stroke/systemic embolic events (SEE) and major bleeding in patients with AF than office BP. Methods: In this prespecified subcohort study of the ANAFIE (All Nippon AF in the Elderly) Registry, we evaluated the impact of home BP on the risk of stroke/SEE, major bleeding, intracranial hemorrhage, all-cause death, and net cardiovascular outcome (a composite of stroke/SEE and major bleeding). At enrollment, home BP was measured twice in the morning and evening for 7 days. Results: In total, 4933 elderly patients (aged ≥75 years) with nonvalvular AF participated. Incidences of net cardiovascular outcome, stroke/SEE, major bleeding, and intracranial hemorrhage increased significantly with increasing home systolic BP (H-SBP). Compared with H-SBP <125 mm Hg, ≥145 mm Hg was associated with increased risk of these events. The association between H-SBP and the events was observed only in patients with ≥20 H-SBP measurements. Conclusions: In elderly patients with nonvalvular AF, high H-SBP (≥145 mm Hg) was a significant predictor of stroke/SEE, major bleeding, and intracranial hemorrhage risk. Strict BP control guided by the increasing number of home BP measurements may provide an accurate clinical outcome risk assessment. Registration: URL: https://www.umin.ac.jp/ctr ; Unique identifier: UMIN000024006
- 19 October 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (12) , 2696-2705
Open AccessHome Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry
Background: Blood pressure (BP) fluctuates significantly in patients with atrial fibrillation (AF); office BP measurements seem insufficient to assess AF patient risk accurately. We hypothesized that home BP could better predict the risk of stroke/systemic embolic events (SEE) and major bleeding in patients with AF than office BP. Methods: In this prespecified subcohort study of the ANAFIE (All Nippon AF in the Elderly) Registry, we evaluated the impact of home BP on the risk of stroke/SEE, major bleeding, intracranial hemorrhage, all-cause death, and net cardiovascular outcome (a composite of stroke/SEE and major bleeding). At enrollment, home BP was measured twice in the morning and evening for 7 days. Results: In total, 4933 elderly patients (aged ≥75 years) with nonvalvular AF participated. Incidences of net cardiovascular outcome, stroke/SEE, major bleeding, and intracranial hemorrhage increased significantly with increasing home systolic BP (H-SBP). Compared with H-SBP <125 mm Hg, ≥145 mm Hg was associated with increased risk of these events. The association between H-SBP and the events was observed only in patients with ≥20 H-SBP measurements. Conclusions: In elderly patients with nonvalvular AF, high H-SBP (≥145 mm Hg) was a significant predictor of stroke/SEE, major bleeding, and intracranial hemorrhage risk. Strict BP control guided by the increasing number of home BP measurements may provide an accurate clinical outcome risk assessment. Registration: URL: https://www.umin.ac.jp/ctr ; Unique identifier: UMIN000024006
- Open Access
- 20 April 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (8) , 2549-2558
Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry
BACKGROUND: We determined the long-term event incidence among elderly patients with nonvalvular atrial fibrillation in terms of history of stroke/transient ischemic attack (TIA) and oral anticoagulation. METHODS: Patients aged ≥75 years with documented nonvalvular atrial fibrillation enrolled in the prospective, multicenter, observational All Nippon Atrial Fibrillation in the Elderly Registry between October 2016 and January 2018 were divided into 2 groups according to history of stroke/TIA. The primary end point was the occurrence of stroke/systemic embolism within 2 years, and secondary end points were major bleeding and all-cause death within 2 years. Cox models were used to determine whether there was a difference in the hazard of each end point in patients with/without history of stroke/TIA, and in ischemic stroke/TIA survivors taking direct oral anticoagulants versus those taking warfarin. RESULTS: Of 32 275 evaluable patients (13 793 women [42.7%]; median age, 81.0 years), 7304 (22.6%) had a history of stroke/TIA. The patients with previous stroke/TIA were more likely to be male and older and had higher hazard rates of stroke/systemic embolism (adjusted hazard ratio, 2.25 [95% CI, 1.97–2.58]), major bleeding (1.25, 1.05–1.49), and all-cause death (1.13, 1.02–1.24) than the other groups. Of 6446 patients with prior ischemic stroke/TIA, 4393 (68.2%) were taking direct oral anticoagulants and 1668 (25.9%) were taking warfarin at enrollment. The risk of stroke/systemic embolism was comparable between these 2 groups (adjusted hazard ratio, 0.90 [95% CI, 0.71–1.14]), while the risk of major bleeding (0.67, 0.48–0.94), intracranial hemorrhage (0.57, 0.39–0.85), and cardiovascular death (0.71, 0.51–0.99) was lower among those taking direct oral anticoagulants. CONCLUSIONS: Patients aged ≥75 years with nonvalvular atrial fibrillation and previous stroke/TIA more commonly had subsequent ischemic and hemorrhagic events than those without previous stroke/TIA. Among patients with previous ischemic stroke/TIA, the risk of hemorrhagic events was lower in patients taking direct oral anticoagulants compared with warfarin. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique Identifier: UMIN000024006. Download figure Download PowerPoint
- 20 April 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (8) , 2549-2558
Open AccessImpact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry
BACKGROUND: We determined the long-term event incidence among elderly patients with nonvalvular atrial fibrillation in terms of history of stroke/transient ischemic attack (TIA) and oral anticoagulation. METHODS: Patients aged ≥75 years with documented nonvalvular atrial fibrillation enrolled in the prospective, multicenter, observational All Nippon Atrial Fibrillation in the Elderly Registry between October 2016 and January 2018 were divided into 2 groups according to history of stroke/TIA. The primary end point was the occurrence of stroke/systemic embolism within 2 years, and secondary end points were major bleeding and all-cause death within 2 years. Cox models were used to determine whether there was a difference in the hazard of each end point in patients with/without history of stroke/TIA, and in ischemic stroke/TIA survivors taking direct oral anticoagulants versus those taking warfarin. RESULTS: Of 32 275 evaluable patients (13 793 women [42.7%]; median age, 81.0 years), 7304 (22.6%) had a history of stroke/TIA. The patients with previous stroke/TIA were more likely to be male and older and had higher hazard rates of stroke/systemic embolism (adjusted hazard ratio, 2.25 [95% CI, 1.97–2.58]), major bleeding (1.25, 1.05–1.49), and all-cause death (1.13, 1.02–1.24) than the other groups. Of 6446 patients with prior ischemic stroke/TIA, 4393 (68.2%) were taking direct oral anticoagulants and 1668 (25.9%) were taking warfarin at enrollment. The risk of stroke/systemic embolism was comparable between these 2 groups (adjusted hazard ratio, 0.90 [95% CI, 0.71–1.14]), while the risk of major bleeding (0.67, 0.48–0.94), intracranial hemorrhage (0.57, 0.39–0.85), and cardiovascular death (0.71, 0.51–0.99) was lower among those taking direct oral anticoagulants. CONCLUSIONS: Patients aged ≥75 years with nonvalvular atrial fibrillation and previous stroke/TIA more commonly had subsequent ischemic and hemorrhagic events than those without previous stroke/TIA. Among patients with previous ischemic stroke/TIA, the risk of hemorrhagic events was lower in patients taking direct oral anticoagulants compared with warfarin. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique Identifier: UMIN000024006. Download figure Download PowerPoint
- Open Access
- 8 October 2021
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 37, 100885
Clinical phenotypes of patients with non-valvular atrial fibrillation as defined by a cluster analysis: A report from the J-RHYTHM registry
- 8 October 2021
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 37, 100885
Open AccessClinical phenotypes of patients with non-valvular atrial fibrillation as defined by a cluster analysis: A report from the J-RHYTHM registry
- Open Access
- 1 August 2020
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 29, 100559
Predictive ability of creatinine clearance versus estimated glomerular filtration rate for outcomes in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry
- 1 August 2020
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 29, 100559
Open AccessPredictive ability of creatinine clearance versus estimated glomerular filtration rate for outcomes in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry
- 10 June 2015
- Published by Elsevier in Thrombosis Research
- Vol. 136 (2) , 267-273
Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM Registry
- 10 June 2015
- Published by Elsevier in Thrombosis Research
- Vol. 136 (2) , 267-273
Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM Registry
- Open Access
- 1 January 2011
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 75 (8) , 1819-1820
Thrombin Inhibitor or Factor Xa Inhibitor?
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2011
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 75 (8) , 1819-1820
Open AccessThrombin Inhibitor or Factor Xa Inhibitor?
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2011
- Published by Elsevier in Journal of Cardiology
- Vol. 57 (1) , 95-99
Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation—The J-RHYTHM Registry study design
- 1 January 2011
- Published by Elsevier in Journal of Cardiology
- Vol. 57 (1) , 95-99
Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation—The J-RHYTHM Registry study design